ROSART

This brand name is authorized in Nigeria. It is also authorized in Singapore.

Active ingredients

The drug ROSART contains one active pharmaceutical ingredient (API):

1	Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-8238	Tablet	Rosart Tablets 50mg TAB 50 mg 510packs	Rosart Tablets 50mg LOSARTAN POTASSIUM TABLETS Losartan Potassium 50mg, Titanium Dioxide, Microcystalline Cellulose, Lactose, Magnesium Stearate, Pregelatinised Starch, Opadry White, Purified Talc, Purified Water Apr-38 Drugs Imported Products 510packs POM 2 04/05/2022 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com Sun Pharmaceutical Ind. Ltd (India), Plot No. B-2, Madkai Industrial Estate, Ponda, Goa - 403404, India, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA01	Losartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-8237, 04-8238
SG	Health Sciences Authority	14314P, 14315P